MacuClear is Drug Discovery in United States that focus on diabetic retinopathy business. Founded in 2006. They cover business area such as developer, small molecule product, ophthalmic treatment, age-relate disease, progression, cause, blindness and vision impairment, dry age relate macular degeneration, aging, central vision, wet and dry form, dAMD.
2006
( 18 years old in 2024 )
Diabetic Retinopathy
-
1755 North Collins
Suite 510
Richardson, TX 75080
United States
Private
developersmall molecule productophthalmic treatmentage-relate diseaseprogressioncauseblindness and vision impairmentdry age relate macular degenerationagingcentral visionwet and dry formdAMD
* We use standard office opening hours in near MacuClear's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
MacuClear is Drug Discovery business from United States that founded in 2006 (18 years old in 2024), MacuClear business is focusing on Diabetic Retinopathy.
MacuClear headquarter office and corporate office address is located in 1755 North Collins Suite 510 Richardson, TX 75080 United States.
MacuClear was founded in United States.
In 2024, MacuClear is currently focus on diabetic retinopathy sector.
Above is snippet of Google Trends for "diabetic retinopathy" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with MacuClear, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
